|
Jan 12
|
EyePoint Pharmaceuticals Inc's Chief Medical Officer Dario Paggiarino Sells 22,913 Shares
|
|
Jan 10
|
EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema
|
|
Dec 20
|
EyePoint Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 18
|
What EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) 194% Share Price Gain Is Not Telling You
|
|
Dec 8
|
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
|
|
Dec 8
|
Wall Street Analysts Believe EyePoint Pharmaceuticals (EYPT) Could Rally 77.05%: Here's is How to Trade
|
|
Dec 8
|
What Makes EyePoint Pharmaceuticals (EYPT) a Good Fit for 'Trend Investing'
|
|
Dec 7
|
Insider Sell Alert: Chief Corp Dev. & Strat. ...
|
|
Dec 7
|
Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data
|
|
Dec 6
|
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
|
|
Dec 5
|
EyePoint (EYPT) Surges 178% on Upbeat Phase II Eye Disease Data
|
|
Dec 4
|
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
|
|
Dec 4
|
EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints
|
|
Dec 4
|
EyePoint sees stock surge on AMD drug trial data
|
|
Nov 3
|
Need To Know: Analysts Are Much More Bullish On EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Revenues
|
|
Nov 2
|
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2023 Earnings Call Transcript
|
|
Oct 21
|
EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholders have endured a 66% loss from investing in the stock five years ago
|
|
Oct 16
|
EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
|
|
Jul 17
|
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
|
|
Apr 26
|
EyePoint Pharmaceuticals to Report First Quarter 2023 Financial Results on May 3, 2023
|